Cynthia X Ma

37PUBLICATIONS
378CO-AUTHORS
Molecular targetsCancer diagnosisTumour immunologyPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|May 26, 2026
Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

|Apr 17, 2026
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

|Apr 13, 2026
Author Correction: O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer.

Yi Zhang, Shuyan Zhou, Yan Kai

|Feb 06, 2026
Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial.

Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang

|Jan 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Tim Kong, Alex Mabry, Maureen Highkin

|Aug 25, 2025
Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.

Lorenzo Gerratana, Carolina Reduzzi, Yue Ren

Pageof 7

Frequent Collaborators

8 joint publications

Foluso O Ademuyiwa

7 joint publications

Li Ding

6 joint publications

Sherri R Davies

5 joint publications

Wenge Zhu